Infection of Epstein-Barr Virus is Associated with the Decrease of Helios+FoxP3+Regulatory T Cells in Active Ulcerative Colitis Patients

被引:7
作者
Long, Yan [1 ]
Zhao, Xiaotao [1 ]
Xia, Changsheng [1 ]
Liu, Xinyu [2 ]
Fan, Chunhong [1 ]
Liu, Chen [1 ]
机构
[1] Peking Univ Peoples Hosp, Dept Clin Lab, 11 Xizhimen South St, Beijing 100044, Peoples R China
[2] Peking Univ Peoples Hosp, Dept Gastroenterol, Beijing, Peoples R China
基金
北京市自然科学基金; 中国国家自然科学基金;
关键词
Helios; regulatory T cells; Epstein-Barr virus; ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; GUT MICROBIOTA; PATHOGENESIS; CYTOMEGALOVIRUS; EXPRESSION; HELIOS;
D O I
10.1080/08820139.2020.1723021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Loss of immune homeostasis to enteric pathogens is considered to be involved in the pathogenesis of ulcerative colitis (UC), and regulatory T cells (Tregs) are key for this immune homeostasis. Helios exhibits an important effect on regulating the suppressive function of Tregs. Epstein-Barr virus (EBV) is more commonly detected in UC. However, whether there is an association between EBV infection and Helios(+)Tregs and its impact on disease activity of UC remain unclear. We aimed to explore the clinical significance of Helios(+)Tregs and their potential association with EBV infection in UC. Methods: Seventy-six UC patients and 38 controls were consecutively enrolled. Helios(+)FoxP3(+)Tregs were analyzed using flow cytometry and compared among groups. Eight active UC patients treated with 5-aminosalicylic acid were followed up. Correlation analyses were conducted between Helios(+)FoxP3(+)Tregs and disease activity indicators. In addition, EBV viral loads in the mucosal lesion were quantified in active UC by quantitative polymerase chain reaction and were comprehensively analyzed in subgroups of different disease severity, and their associations with Helios(+)FoxP3(+)Tregs were also analyzed. Results: Helios(+)FoxP3(+)Tregs were significantly decreased in active UC and were inversely correlated with serum C-reactive protein and Mayo score. Moreover, we observed the recovery of Helios(+)FoxP3(+)Tregs in followed-up active UC achieving remission after treatment. EBV loads were higher in active UC, and levels of Helios(+)FoxP3(+)Tregs in the EBV-positive subgroup were lower than the EBV-negative subgroup in moderate and severe active patients. Most importantly, we found that Helios(+)FoxP3(+)Tregs were significantly negatively correlated with EBV viral loads. Conclusion: Helios(+)FoxP3(+)Tregs are likely to play a pivotal role in disease activity of UC and may be influenced by EBV infection.
引用
收藏
页码:23 / 36
页数:14
相关论文
共 38 条
  • [1] Human cytomegalovirus and epstein-barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement
    Ciccocioppo, Rachele
    Racca, Francesca
    Paolucci, Stefania
    Campanini, Giulia
    Pozzi, Lodovica
    Betti, Elena
    Riboni, Roberta
    Vanoli, Alessandro
    Baldanti, Fausto
    Corazza, Gino Roberto
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (06) : 1915 - 1926
  • [2] Optimal treatment for chronic active Epstein-Barr virus disease
    Cohen, Jeffrey I.
    [J]. PEDIATRIC TRANSPLANTATION, 2009, 13 (04) : 393 - 396
  • [3] Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon
    Cui, Huantian
    Cai, Yuzi
    Wang, Li
    Jia, Beitian
    Li, Junchen
    Zhao, Shuwu
    Chu, Xiaoqian
    Lin, Jin
    Zhang, Xiaoyu
    Bian, Yuhong
    Zhuang, Pengwei
    [J]. FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [4] A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
    D'Haens, Geert
    Sandborn, William J.
    Feagan, Brian G.
    Geboes, Karel
    Hanauer, Stephen B.
    Irvine, E. Jan
    Lemann, Marc
    Marteau, Philippe
    Rutgeerts, Paul
    Scholmerich, Jurgen
    Sutherland, Lloyd R.
    [J]. GASTROENTEROLOGY, 2007, 132 (02) : 763 - 786
  • [5] Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis
    da Silva, Bruno Cesar
    Lyra, Andre Castro
    Rocha, Raquel
    Santana, Genoile Oliveira
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (28) : 9458 - 9467
  • [6] MEDICAL PROGRESS Ulcerative Colitis
    Danese, Silvio
    Fiocchi, Claudio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (18) : 1713 - 1725
  • [7] Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease
    Daryani, Nasser Ebrahimi
    Saghazadeh, Amene
    Moossavi, Shirin
    Sadr, Maryam
    Shahkarami, Sepideh
    Soltani, Samaneh
    Farhadi, Elham
    Rezaei, Nima
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 2017, 46 (07) : 714 - 729
  • [8] Mucosal Profiles of Immune Molecules Related to T Helper and Regulatory T Cells Predict Future Relapse in Patients With Quiescent Ulcerative Colitis
    Fukaura, Keita
    Iboshi, Yoichiro
    Ogino, Haruei
    Ihara, Eikichi
    Nakamura, Kazuhiko
    Nishihara, Yuichiro
    Nishioka, Kei
    Chinen, Takatoshi
    Iwasa, Tsutomu
    Aso, Akira
    Goto, Ayako
    Haraguchi, Kazuhiro
    Akiho, Hirotada
    Harada, Naohiko
    Ogawa, Yoshihiro
    [J]. INFLAMMATORY BOWEL DISEASES, 2019, 25 (06) : 1019 - 1027
  • [9] A role for the transcription factor Helios in human CD4+CD25+ regulatory T cells
    Getnet, Derese
    Grosso, Joseph F.
    Goldberg, Monica V.
    Harris, Timothy J.
    Yen, Hung-Rong
    Bruno, Tullia C.
    Durham, Nicholas M.
    Hipkiss, Edward L.
    Pyle, Kristin J.
    Wada, Satoshi
    Pan, Fan
    Pardoll, Drew M.
    Drake, Charles G.
    [J]. MOLECULAR IMMUNOLOGY, 2010, 47 (7-8) : 1595 - 1600
  • [10] The Percentage of FoxP3+Helios + Treg Cells Correlates Positively With Disease Activity in Systemic Lupus Erythematosus
    Golding, Amit
    Hasni, Sarfaraz
    Illei, Gabor
    Shevach, Ethan M.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (11): : 2898 - 2906